CN103550160A - Anti-inflammatory drug powder - Google Patents
Anti-inflammatory drug powder Download PDFInfo
- Publication number
- CN103550160A CN103550160A CN201310469146.6A CN201310469146A CN103550160A CN 103550160 A CN103550160 A CN 103550160A CN 201310469146 A CN201310469146 A CN 201310469146A CN 103550160 A CN103550160 A CN 103550160A
- Authority
- CN
- China
- Prior art keywords
- antibiotic medicine
- inflammatory drug
- loose
- drug powder
- obliterating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses an anti-inflammatory drug powder. The anti-inflammatory drug powder treats skin diseases caused by bacterial infection in an application mode and is powder formed after grinding of a sulphadiazine tablet. The anti-inflammatory drug powder has the advantages of a good treatment effect and small side effects.
Description
Technical field
The present invention relates to field of pharmaceutical technology, especially relate to a kind of antibiotic medicine loose.
Background technology
At present, treating for skin disease and wound infection prevention for bacterial infections such as the raw skin ulcer of skin, ulcer, skin sore, take the mode of oral medicine to carry out more, thereby the effective ingredient of the medicine that skin absorbs is less, therapeutic effect is poor, and the side effect that endo-medicine forms health is larger.
Summary of the invention
The object of this invention is to provide a kind of antibiotic medicine loose, it is good that it has therapeutic effect, the feature that side effect is less.
The technical solution adopted in the present invention is: a kind of antibiotic medicine is loose, for treating bacterial infection dermatosis by the mode of obliterating, and the powder faling apart and form for after sulfadiazine slice lapping in described antibiotic medicine.
Described antibiotic medicine is dissipated to less can cross 100 mesh sieves.
The advantage that the present invention has is: therapeutic effect is good, and side effect is less.Antibiotic medicine of the present invention is loose improves for route of administration.; the powder forming after sulfadiazine slice lapping is treated to bacterial infection dermatosis by the mode of outside obliterating, the larger side effect having formed while having avoided medicine for oral administration, simultaneously; increased the absorbtivity of skin to effective ingredient, thereby therapeutic effect is better.And using method is very simple.
The specific embodiment
Embodiment
A kind of antibiotic medicine is loose, for treating bacterial infection dermatosis by the mode of obliterating.Concretely, the powder that fall apart and form for after sulfadiazine slice lapping in this antibiotic medicine.Optimize, this antibiotic medicine is dissipated to less can cross 100 mesh sieves.
Experimental example
Choosing 100 personnel carries out as its clinical verification of 10 days.
Concrete: 20 of the raw skin ulcer persons of skin, wherein fall apart and carry out obliterating treatment in 10 employing antibiotic medicine, every day three times, at every turn appropriate, to fill wound, is as the criterion, and all the other 10 adopt traditional method treatment.20 of skin ulcer persons, wherein fall apart and carry out obliterating treatment in 10 employing antibiotic medicine, every day three times, at every turn appropriate, to fill affected part, is as the criterion, and all the other 10 adopt traditional methods treatment.Need 20 of wound infection preventers, wherein fall apart and carry out obliterating prevention in 10 employing antibiotic medicine, every day three times, at every turn appropriate, to fill wound, is as the criterion, and all the other 10 adopt traditional methods treatment.20 of skin sore persons, wherein fall apart and carry out obliterating treatment in 10 employing antibiotic medicine, every day three times, at every turn appropriate, to fill affected part, is as the criterion, and all the other 10 adopt traditional methods treatment.20 of healthy persons, in the small size obliterating of the not obvious place of skin.
Result is as follows: the raw skin ulcer person of skin adopts that antibiotic medicine is loose carries out obliterating therapist, has 7 people to be clearly better, and adopts traditional method therapist, has 3 people to be clearly better.Skin ulcer person adopts that antibiotic medicine is loose carries out obliterating therapist, has 6 people to be clearly better, and adopts traditional method therapist, has 2 people to be clearly better.Need wound infection preventer to adopt antibiotic medicine to fall apart and carry out obliterating preventer, infecting does not appear in 9 people, adopts traditional method therapist, has 5 people not occur infecting.Skin sore person adopts that antibiotic medicine is loose carries out obliterating therapist, has 8 people to be clearly better, and adopts traditional method therapist, has 4 people to occur being clearly better.The person that do not occur apparent side effect in healthy population.
The above results surface, adopts antibiotic medicine of the present invention loose, by the mode of obliterating, treats bacterial infection dermatosis, has curative effect better, and the little advantage of toxic and side effects.
The foregoing is only the preferred embodiments of the present invention; not thereby limit the scope of the claims of the present invention; every equivalent structure or conversion of equivalent flow process that utilizes description of the present invention to do; or be directly or indirectly used in other relevant technical fields, be all in like manner included in scope of patent protection of the present invention.
Claims (2)
1. an antibiotic medicine is loose, for treating bacterial infection dermatosis by the mode of obliterating, it is characterized in that: the powder faling apart and form for after sulfadiazine slice lapping in described antibiotic medicine.
2. a kind of antibiotic medicine according to claim 1 is loose, it is characterized in that: described antibiotic medicine is dissipated to less can cross 100 mesh sieves.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310469146.6A CN103550160A (en) | 2013-10-10 | 2013-10-10 | Anti-inflammatory drug powder |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310469146.6A CN103550160A (en) | 2013-10-10 | 2013-10-10 | Anti-inflammatory drug powder |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103550160A true CN103550160A (en) | 2014-02-05 |
Family
ID=50004643
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310469146.6A Pending CN103550160A (en) | 2013-10-10 | 2013-10-10 | Anti-inflammatory drug powder |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103550160A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105748490A (en) * | 2016-02-26 | 2016-07-13 | 陈鲜 | Quick scald-healing powder and using method thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1160541A (en) * | 1996-10-17 | 1997-10-01 | 徐朝丰 | Externally applied drug for wet beriberi and its preparation process |
-
2013
- 2013-10-10 CN CN201310469146.6A patent/CN103550160A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1160541A (en) * | 1996-10-17 | 1997-10-01 | 徐朝丰 | Externally applied drug for wet beriberi and its preparation process |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105748490A (en) * | 2016-02-26 | 2016-07-13 | 陈鲜 | Quick scald-healing powder and using method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013155188A5 (en) | ||
| NO20051575L (en) | Use of the quinazoline derivative ZD6474 in combination with gemcitabine and optional ionizing radiation in the treatment of diseases associated with angiogenesis and / or ovarian permeability | |
| NZ591525A (en) | Methods of treatment of complicated skin and skin structure infections using single doses of oritavancin | |
| NZ754328A (en) | Marker for acid sphingomyelinase disorders and uses thereof | |
| CN101371899B (en) | Medicine for treating tympanitis | |
| CN103550160A (en) | Anti-inflammatory drug powder | |
| CN102908408A (en) | Bedsore plaster | |
| CN104815103A (en) | Toxin removal powder | |
| CN103417779A (en) | Medicine for treating teniasis | |
| CN110433242A (en) | Bedsore powder and preparation method thereof | |
| CN102631566A (en) | Traditional Chinese medicine for treating trauma infection | |
| CN103919863B (en) | Speckle, pox, wart dermatosis ablution | |
| CN107308379A (en) | A kind of Chinese medicine for treating rhinitis | |
| CN104840584A (en) | Traditional Chinese medicine washing liquid for treating anal eczema | |
| CN105687645A (en) | Traditional Chinese medicine for treating allergic dermatitis | |
| CN104606295A (en) | Non-antibiotic antifungal externally used medicine | |
| CN104984088A (en) | Traditional Chinese medicine prescription for treating trauma infection | |
| CN106265747A (en) | A kind of Chinese medicine treating decubital ulcer | |
| CN104688768A (en) | External ulcer powder | |
| CN104208100A (en) | Externally applied medicine for treating purulent inflammation | |
| CN103356851B (en) | External medicament for treating bedsore | |
| CN101879232B (en) | Medicament for dissipating stasis, removing stroke and preventing and treating cardiovascular and cerebrovascular diseases | |
| CN109303804A (en) | A kind of Chinese medicine composition of dispelling wind and eliminating dampness and preparation method thereof | |
| CN101810802A (en) | Chinese medicinal composition for treating pulmonary abscess | |
| CN102266430A (en) | Drug for treating mouth and tongue sores and oral ulcers |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140205 |